[NH2:1][C:2]1[C:3]([NH:9][C:10]([C:12]2[N:13]([CH3:22])[N:14]=[C:15]([C:18]([CH3:21])([CH3:20])[CH3:19])[C:16]=2[Cl:17])=O)=[N:4][CH:5]=[C:6](Br)[N:7]=1.[F:23][C:24]([F:36])([F:35])[O:25][C:26]1[CH:31]=[CH:30][CH:29]=[CH:28][C:27]=1B(O)O.C([O-])([O-])=O.[Cs+].[Cs+].C(Cl)Cl>O1CCOCC1.CCOC(C)=O.O>[C:18]([C:15]1[C:16]([Cl:17])=[C:12]([C:10]2[NH:9][C:3]3=[N:4][CH:5]=[C:6]([C:27]4[CH:28]=[CH:29][CH:30]=[CH:31][C:26]=4[O:25][C:24]([F:23])([F:36])[F:35])[N:7]=[C:2]3[N:1]=2)[N:13]([CH3:22])[N:14]=1)([CH3:21])([CH3:20])[CH3:19]To a mixture of 5-tert-butyl-4-chloro-2-methyl-2H-pyrazole-3-carboxylic acid (3-amino-5-bromo-pyrazin-2-yl)-amide (45.0 mg, 0.116 mmol, prepared as described in the previous step), 2-trifluoromethoxy-phenyl-boronic acid (28.7 mg, 0.139 mmol), Cs2CO3 (95 mg, 0.29 mmol) and Pd(dppf)2.DCM (9.5 mg, 0.012 mmol) in 1,4-dioxane (3 mL) was added water (1.5 mL). After stirring at 100° C. for 16 h, the resulting mixture was cooled to room temperature and treated with EtOAc (50 mL), washed with H2O (20 mL), brine (20 mL) and then dried with Na2SO4. Removal of the solvent under reduced pressure followed by flash chromatography of the residue on silica gel (0:100-35:65 EtOAc-hexanes) yielded 2-(5-tert-Butyl-4-chloro-2-methyl-2H-pyrazol-3-yl)-5-(2-trifluoromethoxy-phenyl)-1H-imidazo[4,5-b]pyrazine as a light yellow solid. 1H-NMR (400 MHz, CD3OD) δ: 8.79 (s, 1H), 7.87-7.94 (m, 1H), 7.45-7.64 (m, 3H), 4.14 (s, 3H), 1.44 (s, 9H). Mass Spectrum (LCMS, ESI pos.) Calculated For C20H18ClF3N6O: 451.1 (M+H), Measured: 451.1.